Creation and pilot test results of the dermatology‐specific proxy instrument: the Infants and Toddlers Dermatology Quality of Life

Background Until now, there was no validated dermatology‐specific health‐related quality of life (HRQoL) instrument to be used in youngest patients. Objective To create dermatology‐specific proxy instrument for HRQoL assessment in children from birth to 4 years. Methods International focus groups, i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the European Academy of Dermatology and Venereology 2018-12, Vol.32 (12), p.2288-2294
Hauptverfasser: Chernyshov, P. V., Boffa, M. J., Corso, R., Pustišek, N., Marinovic, B., Manolache, L., Salavastru, C. M., Tiplica, G. S., Kakourou, T., Alexopoulos, A., Nasi, L., Wojciechowska‐Zdrojowy, M., Seniuta, J., Szepietowski, J. C., Erkens, A., Fölster‐Holst, R., Sampogna, F., Chernyshov, A. V., Jemec, G. B., Esmann, S., Mazereeuw‐Hautier, J., Merlos, M., Tomas‐Aragones, L., Marron, S. E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2294
container_issue 12
container_start_page 2288
container_title Journal of the European Academy of Dermatology and Venereology
container_volume 32
creator Chernyshov, P. V.
Boffa, M. J.
Corso, R.
Pustišek, N.
Marinovic, B.
Manolache, L.
Salavastru, C. M.
Tiplica, G. S.
Kakourou, T.
Alexopoulos, A.
Nasi, L.
Wojciechowska‐Zdrojowy, M.
Seniuta, J.
Szepietowski, J. C.
Erkens, A.
Fölster‐Holst, R.
Sampogna, F.
Chernyshov, A. V.
Jemec, G. B.
Esmann, S.
Mazereeuw‐Hautier, J.
Merlos, M.
Tomas‐Aragones, L.
Marron, S. E.
description Background Until now, there was no validated dermatology‐specific health‐related quality of life (HRQoL) instrument to be used in youngest patients. Objective To create dermatology‐specific proxy instrument for HRQoL assessment in children from birth to 4 years. Methods International focus groups, item selection and pilot tests were utilized. In order to avoid the problem of cross‐cultural inequivalence, focus group work and pilot tests were planned simultaneously in all national centres of the project. Comprehensibility, clarity, acceptance and internal consistency of new instrument were checked. Results The title ‘Infants and Toddlers Dermatology Quality of Life’ was chosen for our new instrument with the proposed acronym ‘InToDermQoL’. Focus group work was completed in seven national centres (Croatia, Germany, Greece, Malta, Poland, Romania and Ukraine). A total of 170 families of children with different skin diseases were interviewed, and a pilot version of the instrument was created. Centres from France, Denmark and Spain have joined the project at this stage. Parents of 125 children with skin diseases filled in the pilot versions of the instrument. Good comprehensibility, clarity, acceptance and internal consistency of the InToDermQoL were confirmed. The pilot test results showed that the InToDermQoL questionnaire well differentiates severity‐dependent differences. It was also checked and confirmed during the pilot test that no significant information was missed in the questionnaire. Three age‐specific versions of the InToDermQoL questionnaire with 10, 12 and 15 items, respectively, were approved for field tests. Conclusion The pilot test results showed that the InToDermQoL questionnaire has good comprehensibility, clarity, acceptance and internal consistency and well differentiates severity‐dependent differences. Further validation of the InToDermQoL during international field test will be performed.
doi_str_mv 10.1111/jdv.15229
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2098766497</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2098766497</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3259-42218b5e1a9056eb2a72d6bbccac731a43cea33d7a7b35ff49b7ca3d33aa9dde3</originalsourceid><addsrcrecordid>eNp1kMtu1DAUQC1ERYfSBT-AvIRFWj_yMjs0pS-NVFUq3UY39g24cuLBdgrZdcEH9Bv5EjKdlq7qzd2ce3R9CHnP2QGf3-GNuT3ghRDqFVnwvKwzyWr5miyYEmWmVKF2ydsYbxhjnBf1G7IrGS-VYmJB_iwDQrJ-oDAYurbOJ5owJhowji5F6juafiA1GHpI3vnv09-7-7hGbTur6Tr43xO1Q0xh7HFInx_gs6GDYd7dKK-8MQ5DpEfPBno5grNp2shXtsN3ZKcDF3H_ce6Rb8dfr5an2eri5Gz5ZZVpKQqV5ULwui2Qg2JFia2ASpiybbUGXUkOudQIUpoKqlYWXZerttIgjZQAyhiUe-Tj1juf_XOcf9n0Nmp0Dgb0Y2wEU3VVlrmqZvTTFtXBxxiwa9bB9hCmhrNmE72ZozcP0Wf2w6N2bHs0_8mnyjNwuAV-WYfTy6bm_Oh6q_wH2c2QEg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2098766497</pqid></control><display><type>article</type><title>Creation and pilot test results of the dermatology‐specific proxy instrument: the Infants and Toddlers Dermatology Quality of Life</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Chernyshov, P. V. ; Boffa, M. J. ; Corso, R. ; Pustišek, N. ; Marinovic, B. ; Manolache, L. ; Salavastru, C. M. ; Tiplica, G. S. ; Kakourou, T. ; Alexopoulos, A. ; Nasi, L. ; Wojciechowska‐Zdrojowy, M. ; Seniuta, J. ; Szepietowski, J. C. ; Erkens, A. ; Fölster‐Holst, R. ; Sampogna, F. ; Chernyshov, A. V. ; Jemec, G. B. ; Esmann, S. ; Mazereeuw‐Hautier, J. ; Merlos, M. ; Tomas‐Aragones, L. ; Marron, S. E.</creator><creatorcontrib>Chernyshov, P. V. ; Boffa, M. J. ; Corso, R. ; Pustišek, N. ; Marinovic, B. ; Manolache, L. ; Salavastru, C. M. ; Tiplica, G. S. ; Kakourou, T. ; Alexopoulos, A. ; Nasi, L. ; Wojciechowska‐Zdrojowy, M. ; Seniuta, J. ; Szepietowski, J. C. ; Erkens, A. ; Fölster‐Holst, R. ; Sampogna, F. ; Chernyshov, A. V. ; Jemec, G. B. ; Esmann, S. ; Mazereeuw‐Hautier, J. ; Merlos, M. ; Tomas‐Aragones, L. ; Marron, S. E.</creatorcontrib><description>Background Until now, there was no validated dermatology‐specific health‐related quality of life (HRQoL) instrument to be used in youngest patients. Objective To create dermatology‐specific proxy instrument for HRQoL assessment in children from birth to 4 years. Methods International focus groups, item selection and pilot tests were utilized. In order to avoid the problem of cross‐cultural inequivalence, focus group work and pilot tests were planned simultaneously in all national centres of the project. Comprehensibility, clarity, acceptance and internal consistency of new instrument were checked. Results The title ‘Infants and Toddlers Dermatology Quality of Life’ was chosen for our new instrument with the proposed acronym ‘InToDermQoL’. Focus group work was completed in seven national centres (Croatia, Germany, Greece, Malta, Poland, Romania and Ukraine). A total of 170 families of children with different skin diseases were interviewed, and a pilot version of the instrument was created. Centres from France, Denmark and Spain have joined the project at this stage. Parents of 125 children with skin diseases filled in the pilot versions of the instrument. Good comprehensibility, clarity, acceptance and internal consistency of the InToDermQoL were confirmed. The pilot test results showed that the InToDermQoL questionnaire well differentiates severity‐dependent differences. It was also checked and confirmed during the pilot test that no significant information was missed in the questionnaire. Three age‐specific versions of the InToDermQoL questionnaire with 10, 12 and 15 items, respectively, were approved for field tests. Conclusion The pilot test results showed that the InToDermQoL questionnaire has good comprehensibility, clarity, acceptance and internal consistency and well differentiates severity‐dependent differences. Further validation of the InToDermQoL during international field test will be performed.</description><identifier>ISSN: 0926-9959</identifier><identifier>EISSN: 1468-3083</identifier><identifier>DOI: 10.1111/jdv.15229</identifier><identifier>PMID: 30169902</identifier><language>eng</language><publisher>England</publisher><subject>Child, Preschool ; Comprehension ; Cultural Competency ; Europe ; Focus Groups ; Humans ; Infant ; Infant, Newborn ; Pilot Projects ; Proxy ; Quality of Life ; Severity of Illness Index ; Skin Diseases - complications ; Surveys and Questionnaires</subject><ispartof>Journal of the European Academy of Dermatology and Venereology, 2018-12, Vol.32 (12), p.2288-2294</ispartof><rights>2018 European Academy of Dermatology and Venereology</rights><rights>2018 European Academy of Dermatology and Venereology.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3259-42218b5e1a9056eb2a72d6bbccac731a43cea33d7a7b35ff49b7ca3d33aa9dde3</citedby><cites>FETCH-LOGICAL-c3259-42218b5e1a9056eb2a72d6bbccac731a43cea33d7a7b35ff49b7ca3d33aa9dde3</cites><orcidid>0000-0001-7275-4651</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjdv.15229$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjdv.15229$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30169902$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chernyshov, P. V.</creatorcontrib><creatorcontrib>Boffa, M. J.</creatorcontrib><creatorcontrib>Corso, R.</creatorcontrib><creatorcontrib>Pustišek, N.</creatorcontrib><creatorcontrib>Marinovic, B.</creatorcontrib><creatorcontrib>Manolache, L.</creatorcontrib><creatorcontrib>Salavastru, C. M.</creatorcontrib><creatorcontrib>Tiplica, G. S.</creatorcontrib><creatorcontrib>Kakourou, T.</creatorcontrib><creatorcontrib>Alexopoulos, A.</creatorcontrib><creatorcontrib>Nasi, L.</creatorcontrib><creatorcontrib>Wojciechowska‐Zdrojowy, M.</creatorcontrib><creatorcontrib>Seniuta, J.</creatorcontrib><creatorcontrib>Szepietowski, J. C.</creatorcontrib><creatorcontrib>Erkens, A.</creatorcontrib><creatorcontrib>Fölster‐Holst, R.</creatorcontrib><creatorcontrib>Sampogna, F.</creatorcontrib><creatorcontrib>Chernyshov, A. V.</creatorcontrib><creatorcontrib>Jemec, G. B.</creatorcontrib><creatorcontrib>Esmann, S.</creatorcontrib><creatorcontrib>Mazereeuw‐Hautier, J.</creatorcontrib><creatorcontrib>Merlos, M.</creatorcontrib><creatorcontrib>Tomas‐Aragones, L.</creatorcontrib><creatorcontrib>Marron, S. E.</creatorcontrib><title>Creation and pilot test results of the dermatology‐specific proxy instrument: the Infants and Toddlers Dermatology Quality of Life</title><title>Journal of the European Academy of Dermatology and Venereology</title><addtitle>J Eur Acad Dermatol Venereol</addtitle><description>Background Until now, there was no validated dermatology‐specific health‐related quality of life (HRQoL) instrument to be used in youngest patients. Objective To create dermatology‐specific proxy instrument for HRQoL assessment in children from birth to 4 years. Methods International focus groups, item selection and pilot tests were utilized. In order to avoid the problem of cross‐cultural inequivalence, focus group work and pilot tests were planned simultaneously in all national centres of the project. Comprehensibility, clarity, acceptance and internal consistency of new instrument were checked. Results The title ‘Infants and Toddlers Dermatology Quality of Life’ was chosen for our new instrument with the proposed acronym ‘InToDermQoL’. Focus group work was completed in seven national centres (Croatia, Germany, Greece, Malta, Poland, Romania and Ukraine). A total of 170 families of children with different skin diseases were interviewed, and a pilot version of the instrument was created. Centres from France, Denmark and Spain have joined the project at this stage. Parents of 125 children with skin diseases filled in the pilot versions of the instrument. Good comprehensibility, clarity, acceptance and internal consistency of the InToDermQoL were confirmed. The pilot test results showed that the InToDermQoL questionnaire well differentiates severity‐dependent differences. It was also checked and confirmed during the pilot test that no significant information was missed in the questionnaire. Three age‐specific versions of the InToDermQoL questionnaire with 10, 12 and 15 items, respectively, were approved for field tests. Conclusion The pilot test results showed that the InToDermQoL questionnaire has good comprehensibility, clarity, acceptance and internal consistency and well differentiates severity‐dependent differences. Further validation of the InToDermQoL during international field test will be performed.</description><subject>Child, Preschool</subject><subject>Comprehension</subject><subject>Cultural Competency</subject><subject>Europe</subject><subject>Focus Groups</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Pilot Projects</subject><subject>Proxy</subject><subject>Quality of Life</subject><subject>Severity of Illness Index</subject><subject>Skin Diseases - complications</subject><subject>Surveys and Questionnaires</subject><issn>0926-9959</issn><issn>1468-3083</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMtu1DAUQC1ERYfSBT-AvIRFWj_yMjs0pS-NVFUq3UY39g24cuLBdgrZdcEH9Bv5EjKdlq7qzd2ce3R9CHnP2QGf3-GNuT3ghRDqFVnwvKwzyWr5miyYEmWmVKF2ydsYbxhjnBf1G7IrGS-VYmJB_iwDQrJ-oDAYurbOJ5owJhowji5F6juafiA1GHpI3vnv09-7-7hGbTur6Tr43xO1Q0xh7HFInx_gs6GDYd7dKK-8MQ5DpEfPBno5grNp2shXtsN3ZKcDF3H_ce6Rb8dfr5an2eri5Gz5ZZVpKQqV5ULwui2Qg2JFia2ASpiybbUGXUkOudQIUpoKqlYWXZerttIgjZQAyhiUe-Tj1juf_XOcf9n0Nmp0Dgb0Y2wEU3VVlrmqZvTTFtXBxxiwa9bB9hCmhrNmE72ZozcP0Wf2w6N2bHs0_8mnyjNwuAV-WYfTy6bm_Oh6q_wH2c2QEg</recordid><startdate>201812</startdate><enddate>201812</enddate><creator>Chernyshov, P. V.</creator><creator>Boffa, M. J.</creator><creator>Corso, R.</creator><creator>Pustišek, N.</creator><creator>Marinovic, B.</creator><creator>Manolache, L.</creator><creator>Salavastru, C. M.</creator><creator>Tiplica, G. S.</creator><creator>Kakourou, T.</creator><creator>Alexopoulos, A.</creator><creator>Nasi, L.</creator><creator>Wojciechowska‐Zdrojowy, M.</creator><creator>Seniuta, J.</creator><creator>Szepietowski, J. C.</creator><creator>Erkens, A.</creator><creator>Fölster‐Holst, R.</creator><creator>Sampogna, F.</creator><creator>Chernyshov, A. V.</creator><creator>Jemec, G. B.</creator><creator>Esmann, S.</creator><creator>Mazereeuw‐Hautier, J.</creator><creator>Merlos, M.</creator><creator>Tomas‐Aragones, L.</creator><creator>Marron, S. E.</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7275-4651</orcidid></search><sort><creationdate>201812</creationdate><title>Creation and pilot test results of the dermatology‐specific proxy instrument: the Infants and Toddlers Dermatology Quality of Life</title><author>Chernyshov, P. V. ; Boffa, M. J. ; Corso, R. ; Pustišek, N. ; Marinovic, B. ; Manolache, L. ; Salavastru, C. M. ; Tiplica, G. S. ; Kakourou, T. ; Alexopoulos, A. ; Nasi, L. ; Wojciechowska‐Zdrojowy, M. ; Seniuta, J. ; Szepietowski, J. C. ; Erkens, A. ; Fölster‐Holst, R. ; Sampogna, F. ; Chernyshov, A. V. ; Jemec, G. B. ; Esmann, S. ; Mazereeuw‐Hautier, J. ; Merlos, M. ; Tomas‐Aragones, L. ; Marron, S. E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3259-42218b5e1a9056eb2a72d6bbccac731a43cea33d7a7b35ff49b7ca3d33aa9dde3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Child, Preschool</topic><topic>Comprehension</topic><topic>Cultural Competency</topic><topic>Europe</topic><topic>Focus Groups</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Pilot Projects</topic><topic>Proxy</topic><topic>Quality of Life</topic><topic>Severity of Illness Index</topic><topic>Skin Diseases - complications</topic><topic>Surveys and Questionnaires</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chernyshov, P. V.</creatorcontrib><creatorcontrib>Boffa, M. J.</creatorcontrib><creatorcontrib>Corso, R.</creatorcontrib><creatorcontrib>Pustišek, N.</creatorcontrib><creatorcontrib>Marinovic, B.</creatorcontrib><creatorcontrib>Manolache, L.</creatorcontrib><creatorcontrib>Salavastru, C. M.</creatorcontrib><creatorcontrib>Tiplica, G. S.</creatorcontrib><creatorcontrib>Kakourou, T.</creatorcontrib><creatorcontrib>Alexopoulos, A.</creatorcontrib><creatorcontrib>Nasi, L.</creatorcontrib><creatorcontrib>Wojciechowska‐Zdrojowy, M.</creatorcontrib><creatorcontrib>Seniuta, J.</creatorcontrib><creatorcontrib>Szepietowski, J. C.</creatorcontrib><creatorcontrib>Erkens, A.</creatorcontrib><creatorcontrib>Fölster‐Holst, R.</creatorcontrib><creatorcontrib>Sampogna, F.</creatorcontrib><creatorcontrib>Chernyshov, A. V.</creatorcontrib><creatorcontrib>Jemec, G. B.</creatorcontrib><creatorcontrib>Esmann, S.</creatorcontrib><creatorcontrib>Mazereeuw‐Hautier, J.</creatorcontrib><creatorcontrib>Merlos, M.</creatorcontrib><creatorcontrib>Tomas‐Aragones, L.</creatorcontrib><creatorcontrib>Marron, S. E.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chernyshov, P. V.</au><au>Boffa, M. J.</au><au>Corso, R.</au><au>Pustišek, N.</au><au>Marinovic, B.</au><au>Manolache, L.</au><au>Salavastru, C. M.</au><au>Tiplica, G. S.</au><au>Kakourou, T.</au><au>Alexopoulos, A.</au><au>Nasi, L.</au><au>Wojciechowska‐Zdrojowy, M.</au><au>Seniuta, J.</au><au>Szepietowski, J. C.</au><au>Erkens, A.</au><au>Fölster‐Holst, R.</au><au>Sampogna, F.</au><au>Chernyshov, A. V.</au><au>Jemec, G. B.</au><au>Esmann, S.</au><au>Mazereeuw‐Hautier, J.</au><au>Merlos, M.</au><au>Tomas‐Aragones, L.</au><au>Marron, S. E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Creation and pilot test results of the dermatology‐specific proxy instrument: the Infants and Toddlers Dermatology Quality of Life</atitle><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle><addtitle>J Eur Acad Dermatol Venereol</addtitle><date>2018-12</date><risdate>2018</risdate><volume>32</volume><issue>12</issue><spage>2288</spage><epage>2294</epage><pages>2288-2294</pages><issn>0926-9959</issn><eissn>1468-3083</eissn><abstract>Background Until now, there was no validated dermatology‐specific health‐related quality of life (HRQoL) instrument to be used in youngest patients. Objective To create dermatology‐specific proxy instrument for HRQoL assessment in children from birth to 4 years. Methods International focus groups, item selection and pilot tests were utilized. In order to avoid the problem of cross‐cultural inequivalence, focus group work and pilot tests were planned simultaneously in all national centres of the project. Comprehensibility, clarity, acceptance and internal consistency of new instrument were checked. Results The title ‘Infants and Toddlers Dermatology Quality of Life’ was chosen for our new instrument with the proposed acronym ‘InToDermQoL’. Focus group work was completed in seven national centres (Croatia, Germany, Greece, Malta, Poland, Romania and Ukraine). A total of 170 families of children with different skin diseases were interviewed, and a pilot version of the instrument was created. Centres from France, Denmark and Spain have joined the project at this stage. Parents of 125 children with skin diseases filled in the pilot versions of the instrument. Good comprehensibility, clarity, acceptance and internal consistency of the InToDermQoL were confirmed. The pilot test results showed that the InToDermQoL questionnaire well differentiates severity‐dependent differences. It was also checked and confirmed during the pilot test that no significant information was missed in the questionnaire. Three age‐specific versions of the InToDermQoL questionnaire with 10, 12 and 15 items, respectively, were approved for field tests. Conclusion The pilot test results showed that the InToDermQoL questionnaire has good comprehensibility, clarity, acceptance and internal consistency and well differentiates severity‐dependent differences. Further validation of the InToDermQoL during international field test will be performed.</abstract><cop>England</cop><pmid>30169902</pmid><doi>10.1111/jdv.15229</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-7275-4651</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0926-9959
ispartof Journal of the European Academy of Dermatology and Venereology, 2018-12, Vol.32 (12), p.2288-2294
issn 0926-9959
1468-3083
language eng
recordid cdi_proquest_miscellaneous_2098766497
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Child, Preschool
Comprehension
Cultural Competency
Europe
Focus Groups
Humans
Infant
Infant, Newborn
Pilot Projects
Proxy
Quality of Life
Severity of Illness Index
Skin Diseases - complications
Surveys and Questionnaires
title Creation and pilot test results of the dermatology‐specific proxy instrument: the Infants and Toddlers Dermatology Quality of Life
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T14%3A14%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Creation%20and%20pilot%20test%20results%20of%20the%20dermatology%E2%80%90specific%20proxy%20instrument:%20the%20Infants%20and%20Toddlers%20Dermatology%20Quality%20of%20Life&rft.jtitle=Journal%20of%20the%20European%20Academy%20of%20Dermatology%20and%20Venereology&rft.au=Chernyshov,%20P.%20V.&rft.date=2018-12&rft.volume=32&rft.issue=12&rft.spage=2288&rft.epage=2294&rft.pages=2288-2294&rft.issn=0926-9959&rft.eissn=1468-3083&rft_id=info:doi/10.1111/jdv.15229&rft_dat=%3Cproquest_cross%3E2098766497%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2098766497&rft_id=info:pmid/30169902&rfr_iscdi=true